Rising Star: Skadden's Chadé Severin
Chadé Severin of Skadden Arps Slate Meagher & Flom LLP drove complex deals in the biopharma sector, including Gilead's $4.9 billion acquisition of cancer immunotherapy firm Forty Seven Inc., landing her...To view the full article, register now.
Already a subscriber? Click here to view full article